Monasterium Laboratory’s Innovation program

Innovation is our passion. Together with our scientists and our established global network, we run basic & translational research programs and clinical study designs to develop and offer novel innovative technologies and methodologies to our clients.

Some of the established methodologies that we apply include xenotransplantation, optical coherence tomography and many more to further enhance our understanding in the field of hair and skin research.

Besides co-funding several projects with world-renowned pharma or cosmetic companies to develop innovative technologies and methodologies (co-development projects, and co-founded PhD projects), our current in house innovation programs include:

Novel technology program

To meet the current market needs in hair and dermatology fields, we conduct innovation projects and clinical study designs that lead to the identification of breakthrough novel hair and skin actives and the development of high-end technologies. Our innovative program is delivering a pipeline of next-generation pharmaceutical, cosmeceutical and nutraceutical tools for hair and skin solutions. We offer our clients priority access to intellectual property rights, such as exclusive licenses on these innovative technologies.

Advanced methodology program

Our projects aim at developing cutting-edge, clinically relevant human in vitro, ex vivo and in vivo models to be employed in skin and hair research to further expand the robust, versatile, one-of-a-kind service portfolio of the company.
In 2019, we have launched many new innovative services for our clients. Please click here to know more about our new services.

Innovative Research: Olfactory Receptors in Hair follicles

As example, please see “Hair Follicles Can Smell: Olfactory Receptor OR2AT4 Regulates Human Hair Growth” (Read the full story).

We revealed for the first time, that human hair follicles express a specific olfactory (smell) receptor, called OR2AT4. Importantly for hair research, we discovered that when this olfactory receptor is stimulated with Sandalore®, a synthetic mimic of natural sandalwood oil, hair follicles remain in anagen longer ex vivo. This research demonstrated that the activation of OR2AT4 is a promising cosmeceutical strategy for treating hair growth disorders. As a direct result of this exciting research, the technology was sold to Giuliani S.p.A, which added Bioscalin® Signal-Revolution for hair fall to its hair care range in 2016.

Please do not hesitate to contact us for any further discussion about our study design and innovation program.